Bulletin
Investor Alert

New York Markets Open in:

Healthpeak Properties Inc.

NYS: PEAK

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Dec 2, 2022, 8:02 a.m.

/zigman2/quotes/205497622/composite

$

26.15

Change

0.00 0.00%

Volume

Volume 4

Quotes are delayed by 20 min

/zigman2/quotes/205497622/composite

Previous close

$ 26.15

$ 26.15

Change

-0.11 -0.42%

Day low

Day high

$26.01

$26.70

Open

52 week low

52 week high

$21.41

$36.85

Open

Insider Actions for Healthpeak Properties Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/16/2022 Christine N. Garvey
Director
1,860   Disposition at $24.76 per share. 46,053
10/03/2022 Troy E. McHenry
CLO and GC
3,822   Derivative/Non-derivative trans. at $22.92 per share. 87,600
10/03/2022 Lisa A. Alonso
EVP and Chief HR Officer
1,031   Derivative/Non-derivative trans. at $22.92 per share. 23,630
08/16/2022 Christine N. Garvey
Director
302   Gift at $0 per share. 0
05/23/2022 Christine N. Garvey
Director
102   Gift at $0 per share. 0
05/15/2022 Peter A. Scott
CFO
8,118   Derivative/Non-derivative trans. at $30.08 per share. 244,189
05/04/2022 Christine N. Garvey
Director
152   Gift at $0 per share. 0
04/28/2022 David B. Henry
Director
5,258   Award at $0 per share. 0
04/28/2022 R. Kent Griffin
Director
5,258   Award at $0 per share. 0
04/28/2022 Brian G. Cartwright
Director
5,258   Award at $0 per share. 0
04/28/2022 Christine N. Garvey
Director
5,258   Award at $0 per share. 0
04/28/2022 Lydia H. Kennard
Director
5,258   Award at $0 per share. 0
04/28/2022 Katherine Mary Sandstrom
Director
5,258   Award at $0 per share. 0
04/28/2022 Sara Grootwassink Lewis
Director
5,258   Award at $0 per share. 0
02/23/2022 Christine N. Garvey
Director
190   Gift at $0 per share. 0
02/15/2022 Thomas M. Herzog
CEO; Director
11,671   Derivative/Non-derivative trans. at $32.1 per share. 374,639
02/15/2022 Thomas M. Klaritch
COO
2,613   Derivative/Non-derivative trans. at $32.1 per share. 83,877
02/15/2022 Scott M. Brinker
President and CIO
3,855   Derivative/Non-derivative trans. at $32.1 per share. 123,745
02/15/2022 Peter A. Scott
CFO
3,221   Derivative/Non-derivative trans. at $32.1 per share. 103,394
02/15/2022 Troy E. McHenry
CLO and GC
2,009   Derivative/Non-derivative trans. at $32.1 per share. 64,488
02/15/2022 Jeffrey H. Miller
EVP - Development
1,740   Derivative/Non-derivative trans. at $32.1 per share. 55,854
02/15/2022 Shawn G. Johnston
EVP and CAO
897   Derivative/Non-derivative trans. at $32.1 per share. 28,793
02/15/2022 Scott Bohn
EVP, Co-Head of Life Science
561   Derivative/Non-derivative trans. at $32.1 per share. 18,008
02/15/2022 Lisa A. Alonso
EVP and Chief HR Officer
718   Derivative/Non-derivative trans. at $32.1 per share. 23,047
02/14/2022 Thomas M. Herzog
CEO; Director
11,672   Derivative/Non-derivative trans. at $32.45 per share. 378,756
02/14/2022 Thomas M. Klaritch
COO
2,116   Derivative/Non-derivative trans. at $32.45 per share. 68,664
02/14/2022 Scott M. Brinker
President and CIO
4,064   Derivative/Non-derivative trans. at $32.45 per share. 131,876
02/14/2022 Peter A. Scott
CFO
2,716   Derivative/Non-derivative trans. at $32.45 per share. 88,134
02/14/2022 Troy E. McHenry
CLO and GC
1,815   Derivative/Non-derivative trans. at $32.45 per share. 58,896
02/14/2022 Jeffrey H. Miller
EVP - Development
786   Derivative/Non-derivative trans. at $32.45 per share. 25,505
02/14/2022 Shawn G. Johnston
EVP and CAO
817   Derivative/Non-derivative trans. at $32.45 per share. 26,511
02/14/2022 Scott Bohn
EVP, Co-Head of Life Science
570   Derivative/Non-derivative trans. at $32.45 per share. 18,496
02/14/2022 Lisa A. Alonso
EVP and Chief HR Officer
322   Derivative/Non-derivative trans. at $32.45 per share. 10,448

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
3 Sales
0
6,713
Last 6 months
0 Purchases
4 Sales
0
7,015
Last 12 months
27 Purchases
42 Sales
593,911
271,916

Officers and Executives

Mr. Scott M. Brinker
President, Chief Executive Officer & Director
Mr. Thomas M. Klaritch
Chief Operating Officer & Executive Vice President
Mr. Peter A. Scott
Chief Financial Officer & Executive Vice President
Mr. Keith Bereskin
SVP-Information Technology & Building Operations
Mr. Adam G. Mabry
Chief Investment Officer
Mr. Andrew Johns
Head-Financial Planning & Analysis Team
Mr. Paul Jin
Senior Vice President-Tax
Ms. Jennee S. Oh
Senior Vice President-Operations
Mr. Scott Bohn
Chief Development Officer & Co-Head-Life Science
Mr. Ankit B. Patadia
Treasurer-Corporate Finance & Senior VP
Mr. David M. Hansen
Senior Vice President & Controller
Mr. Shawn G. Johnston
Chief Accounting Officer & Executive VP
Mr. Andrew W. Johns
Senior Vice President-Investor Relations
Ms. Lisa A. Alonso
Chief Human Resources Officer & Executive VP
Mr. Scott A. Graziano
Secretary, Senior VP & Deputy General Counsel
Mr. Jeffrey H. Miller
General Counsel
Dr. Brian G. Cartwright
Independent Chairman
Ms. Sara Grootwassink Lewis
Independent Director
Ms. Christine N. Garvey
Independent Director
Mr. David B. Henry
Independent Director
Mr. R. Kent Griffin
Independent Director
Ms. Katherine Mary Sandstrom
Vice Chairman
Link to MarketWatch's Slice.